Causaly, a five-year-old drug discovery AI startup that already counts 12 of the top 20 pharmaceutical companies among its customers, today announced a fresh $60 million in series B funding to further expand its footprint in the U.S.The latest funding round is led by ICONIQ Growth along with participating investors Index Ventures, Marathon Ventures, EBRD […]
